Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Garuda Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Garuda Therapeutics

Garuda Therapeutics

Garuda Therapeutics: Developing ready-to-use stem cell therapies for severe diseases.

HQ
Cambridge, MA, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

Garuda Therapeutics, founded in Cambridge, Massachusetts, is dedicated to developing off-the-shelf hematopoietic stem cell (HSC) therapies aimed at treating severe and life-threatening diseases. The company's core mission is to provide accessible and ready-to-use stem cell treatments, revolutionizing the approach to managing critical health conditions. Garuda's vision is to make advanced stem cell therapies widely available, thereby improving patient outcomes across various demographics and medical needs.

Notable figures affiliated with Garuda Therapeutics include Dhvanit Shah, Ph.D., who serves as Co-founder, President, and Chief Executive Officer. The company has garnered attention for its innovative approach and has been recognized by industry awards such as the BioTech Breakthrough Awards. Garuda Therapeutics' impact lies in its potential to transform the landscape of stem cell therapy, offering scalable and immediate solutions for patients in need.

Garuda Therapeutics - Similar Companies

Guardian Therapeutics logo

Guardian Therapeutics

Stemson Therapeutics logo

Stemson Therapeutics

stemsontx.com

APstem Therapeutics logo

APstem Therapeutics

apstemtx.com

Stemedica Cell Technologies logo

Stemedica Cell Technologies

stemedica.com

GC Therapeutics logo

GC Therapeutics

gc-tx.com

Capstan Therapeutics logo

Capstan Therapeutics

capstantx.com

Gallant logo

Gallant

Hepatx logo

Hepatx

hepatx.com

Cellebration Life Sciences logo

Cellebration Life Sciences

Stemcyte logo

Stemcyte

stemcyte.com

ImStem Biotechnology logo

ImStem Biotechnology

imstem.com

Stemgenics logo

Stemgenics

stemgenics.com

Throne Biotechnologies logo

Throne Biotechnologies

thronebio.com

RhinoCyte logo

RhinoCyte

rhinocyte.com

Cell BioEngines logo

Cell BioEngines

cellbioengines.com

Garuda Therapeutics - Quick Facts

Who are Garuda Therapeutics' competitors?

Companies similar to Garuda Therapeutics include Guardian Therapeutics, Stemson Therapeutics, APstem Therapeutics and Stemedica Cell Technologies.

When was Garuda Therapeutics founded?

Garuda Therapeutics was founded in 2021.

Where is Garuda Therapeutics' headquarters located?

Garuda Therapeutics' headquarters is located in Cambridge, MA, US.

When was Garuda Therapeutics' last funding round?

Garuda Therapeutics' most recent funding round was for $62M (USD) in February 2023.

How much has Garuda Therapeutics raised to-date?

As of Feb 7, 2023, Garuda Therapeutics has raised a total of $134M (USD).

How many employees does Garuda Therapeutics have?

Garuda Therapeutics has 67 employees as of Feb 5, 2024.

Garuda Therapeutics - Classification

Ownership
  • Private Equity
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Stem Cell Therapies
Tags
  • Biotech
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified